Antipodes Partners LTD Stryker Corp Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in Stryker Corp stock. As of the latest transaction made, Antipodes Partners LTD holds 91 shares of SYK stock, worth $32,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91Holding current value
$32,771% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SYK
# of Institutions
2,588Shares Held
296MCall Options Held
1.24MPut Options Held
949K-
Vanguard Group Inc Valley Forge, PA33.8MShares$12.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY26.8MShares$9.65 Billion0.21% of portfolio
-
Greenleaf Trust Kalamazoo, MI16.6MShares$5.99 Billion56.34% of portfolio
-
State Street Corp Boston, MA14.9MShares$5.38 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY11.9MShares$4.3 Billion0.29% of portfolio
About STRYKER CORP
- Ticker SYK
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 378,320,992
- Market Cap $136B
- Description
- Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...